Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats
- PMID: 8719804
- PMCID: PMC1909166
- DOI: 10.1111/j.1476-5381.1995.tb15132.x
Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats
Abstract
1. Previous studies have shown that endothelium-dependent relaxation in the aorta of spontaneously diabetic bio bred rats (BB) is impaired. 2. We have investigated noradrenaline (NA) contractility, endothelium-dependent acetylcholine (ACh) and bradykinin (BK) relaxation, and endothelium-independent sodium nitroprusside (SNP) relaxation in mesenteric resistance arteries of recent onset BB rats and established insulin treated BB rats, compared to their age-matched non diabetic controls. 3. There was no significant difference in the maximum contractile response or sensitivity to noradrenaline in either of the diabetic groups compared to their age-matched controls. 4. Incubation with the nitric oxide synthetase inhibitor NG-nitro-L-arginine (L-NOARG) resulted in a significant increase in maximum contractile response to noradrenaline in the recent onset age-matched control group (P < 0.05). Analysis of the whole dose-response curve (using ANOVA for repeated measures with paired t test) showed a significant left-ward shift following the addition of L-NOARG (P < 0.001). A similar but less marked shift (P < 0.01) was evident in vessels from recent onset diabetics. An overall shift in both sensitivity and maximum response was also evident in the age-matched non diabetic controls of the insulin-treated group (P < 0.05). However, by contrast, there was no significant change in sensitivity in the insulin-treated diabetic rats. 5. ACh-induced endothelium-dependent relaxation was significantly impaired in the recent onset diabetic rats compared to their age-matched controls (47 +/- 11% versus 92 +/- 2%, P < 0.05, n = 6), and in the insulin treated diabetic rats (34 +/- 5% versus 75 +/- 6%, P < 0.05, n = 6). The relaxation responses to BK also were significantly impaired in the diabetic rats compared to their age-matched controls (recent onset: 20 +/- 3% versus 72 +/- 7%, P < 0.05, n = 6; insulin treated: 12 +/- 9% versus 68 +/- 7%, P < 0.05, n = 7). 6. Incubation with either the nitric oxide synthetase substrate, U-arginine, or the free radical scavenging enzyme superoxide dismutase (150 mu ml-1) failed to improve the attenuated response of acetylcholine-induced relaxation in the diabetic vessels. 7. Endothelium-dependent relaxation mediated by ACh and BK was significantly attenuated in both the diabetic and control vessels after incubation with L-NOARG. 8. Pretreatment with a cyclo-oxygenase inhibitor, indomethacin, significantly enhanced the relaxation to ACh in both the recent onset and insulin treated diabetic rats (42 +/- 10%, n = 7 versus 64 +/- 7%, n = 7, P < 0.05, and 40 +/- 5%, n = 7 versus 65 +/- 9%, n = 6, P < 0.05). 9. Following endothelium removal, there was a marked impairment in endothelium-dependent relaxation responses to ACh and BK in both the diabetic and control vessels. 10. Incubation with the thromboxane A2 receptor antagonist SQ29548, did not significantly improve the ACh endothelium-dependent relaxation response in the diabetic vessels. 11. Endothelium-independent relaxation to sodium nitroprusside was significantly impaired in the first group of diabetic vessels studied; however, subsequent studies showed no impairment of the sodium nitroprusside response in the diabetic vessels. 12. In conclusion, the ability of the endothelium to regulate vascular contractility is reduced in recent onset diabetic vessels, and significantly impaired in established insulin treated diabetics. Relaxation to the endothelium-dependent vasodilators ACh and BK was impaired in both the recent onset and the established insulin treated diabetics, and the ACh response was significantly improved following pretreatment with indomethacin, suggesting a role for a cyclo-oxygenase-derived vasoconstrictor. Preliminary studies with a thromboxane A2, receptor antagonist, SQ29548 did not significantly improve the impaired relaxation to ACh, indicating that the vasoconstrictor prostanoid is not thromboxane A2.
Similar articles
-
Endothelial adrenoceptors.J Cardiovasc Pharmacol. 2001 Nov;38(5):796-808. doi: 10.1097/00005344-200111000-00016. J Cardiovasc Pharmacol. 2001. PMID: 11602826 Review.
-
The effect of insulin treatment and of islet transplantation on the resistance artery function in the STZ-induced diabetic rat.Br J Pharmacol. 1996 Oct;119(3):495-504. doi: 10.1111/j.1476-5381.1996.tb15699.x. Br J Pharmacol. 1996. PMID: 8894169 Free PMC article.
-
Importance of endothelial function in chronic heart failure.J Cardiovasc Pharmacol. 1996;27 Suppl 2:S9-12. doi: 10.1097/00005344-199600002-00003. J Cardiovasc Pharmacol. 1996. PMID: 8723393 Review.
-
Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenaline-induced contractility in mesenteric resistance arteries from streptozotocin-induced diabetic rats.Br J Pharmacol. 1994 Jan;111(1):35-41. doi: 10.1111/j.1476-5381.1994.tb14020.x. Br J Pharmacol. 1994. PMID: 8012717 Free PMC article.
-
Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin-induced diabetic rats.Br J Pharmacol. 1992 Oct;107(2):393-9. doi: 10.1111/j.1476-5381.1992.tb12757.x. Br J Pharmacol. 1992. PMID: 1422588 Free PMC article.
Cited by
-
Capsaicin Alleviates Vascular Endothelial Dysfunction and Cardiomyopathy via TRPV1/eNOS Pathway in Diabetic Rats.Oxid Med Cell Longev. 2022 May 12;2022:6482363. doi: 10.1155/2022/6482363. eCollection 2022. Oxid Med Cell Longev. 2022. Retraction in: Oxid Med Cell Longev. 2024 Jan 9;2024:9868092. doi: 10.1155/2024/9868092. PMID: 35602097 Free PMC article. Retracted.
-
Heart failure in diabetes.Metabolism. 2021 Dec;125:154910. doi: 10.1016/j.metabol.2021.154910. Epub 2021 Oct 8. Metabolism. 2021. PMID: 34627874 Free PMC article. Review.
-
Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.Acta Pharmacol Sin. 2019 Jan;40(1):1-8. doi: 10.1038/s41401-018-0042-6. Epub 2018 Jun 4. Acta Pharmacol Sin. 2019. PMID: 29867137 Free PMC article. Review.
-
O-Linked β-N-acetylglucosamine (O-GlcNAc) modification: a new pathway to decode pathogenesis of diabetic retinopathy.Clin Sci (Lond). 2018 Jan 19;132(2):185-198. doi: 10.1042/CS20171454. Print 2018 Jan 31. Clin Sci (Lond). 2018. PMID: 29352075 Free PMC article. Review.
-
Oxygen-derived free radicals mediate endothelium-dependent contractions in femoral arteries of rats with streptozotocin-induced diabetes.Br J Pharmacol. 2007 Dec;152(7):1033-41. doi: 10.1038/sj.bjp.0707439. Epub 2007 Sep 3. Br J Pharmacol. 2007. PMID: 17767168 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials